NCT00336674View on ClinicalTrials.gov

Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

November 13, 2019

Study Completion Date

November 13, 2019

Conditions
Type 1 Diabetes
Interventions
BIOLOGICAL

Intranasal insulin

440IU Insulin

OTHER

Placebo

Placebo insulin carrier solution containing benzalkonium chloride and glycerol

Trial Locations (6)

2145

The Children's Hospital at Westmead, Westmead

3050

Royal Melbourne Hospital, Melbourne

4101

Mater Children's Hospital, Brisbane

5006

Womens and Childrens Hospital, North Adelaide

6840

Princess Margaret Hospital, Subiaco

Unknown

University of Auckland, Auckland

Sponsors

Lead Sponsor

Melbourne Health
All Listed Sponsors
lead

Melbourne Health

OTHER

NCT00336674 - Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes | Biotech Hunter | Biotech Hunter